{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T17:57:18Z","timestamp":1761674238257,"version":"3.41.2"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reports"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.pharep.2015.11.010","type":"journal-article","created":{"date-parts":[[2015,12,18]],"date-time":"2015-12-18T02:50:47Z","timestamp":1450407047000},"page":"490-494","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["The effect of metformin on the hypothalamic-pituitary-thyroid axis in patients with type 2 diabetes and amiodarone-induced hypothyroidism"],"prefix":"10.1007","volume":"68","author":[{"given":"Robert","family":"Krysiak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma\u0142gorzata","family":"Gilowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Witold","family":"Szkr\u00f3bka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bogus\u0142aw","family":"Okopie\u0144","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.pharep.2015.11.010_bib0165","first-page":"S42","article-title":"Standards of medical care in diabetes \u2013 2015. Approaches to glycemic treatment","volume":"38","author":"American Diabetes Association","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pharep.2015.11.010_bib0170","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","article-title":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group","volume":"352","author":"U.K. Prospective Diabetes Study Group","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.pharep.2015.11.010_bib0175","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Diabetes Prevention Program Research Group","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharep.2015.11.010_bib0180","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3132\/dvdr.2008.027","article-title":"Metformin therapy and clinical uses","volume":"5","author":"Scarpello","year":"2008","journal-title":"Diabetes Vasc Dis Res"},{"key":"10.1016\/j.pharep.2015.11.010_bib0185","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1210\/jc.2005-1210","article-title":"Thyrotropin suppression by metformin","volume":"91","author":"Vigersky","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharep.2015.11.010_bib0190","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.2337\/dc09-0273","article-title":"TSH-lowering effect of metformin in type 2 diabetic patients: differences between euthyroid, untreated hypothyroid, and euthyroid on L-T4 therapy patients","volume":"32","author":"Cappelli","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pharep.2015.11.010_bib0195","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s12020-007-9012-3","article-title":"Metformin reduces thyrotropin levels in obese, diabetic women with primary hypothyroidism on thyroxine replacement therapy","volume":"32","author":"Isidro","year":"2007","journal-title":"Endocrine"},{"key":"10.1016\/j.pharep.2015.11.010_bib0200","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/1479164110391917","article-title":"Metformin decreases thyrotropin in overweight women with polycystic ovarian syndrome and hypothyroidism","volume":"8","author":"Morteza Taghavi","year":"2011","journal-title":"Diabetes Vasc Dis Res"},{"key":"10.1016\/j.pharep.2015.11.010_bib0205","doi-asserted-by":"crossref","first-page":"E143","DOI":"10.1210\/jc.2013-2965","article-title":"Effects of treatment with metformin on TSH levels: a meta-analysis of literature studies","volume":"99","author":"Lupoli","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharep.2015.11.010_bib0210","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/jcph.373","article-title":"The effect of metformin on the hypothalamic-pituitary-thyroid axis in women with polycystic ovary syndrome and subclinical hypothyroidism","volume":"55","author":"Krysiak","year":"2015","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.pharep.2015.11.010_bib0215","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/BF03350893","article-title":"Three-month treatment with metformin or dexfenfluramine does not modify the effects of diet on anthropometric and endocrine-metabolic parameters in abdominal obesity","volume":"22","author":"Oleandri","year":"1999","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.pharep.2015.11.010_bib0220","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1055\/s-0034-1398621","article-title":"The effect of metformin on the hypothalamic-pituitary-thyroid axis in patients with type 2 diabetes and subclinical hyperthyroidism","volume":"123","author":"Krysiak","year":"2015","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.pharep.2015.11.010_bib0225","first-page":"22","article-title":"Metformin and thyroid: an update","volume":"2","author":"Pappa","year":"2013","journal-title":"Eur Thyroid J"},{"key":"10.1016\/j.pharep.2015.11.010_bib0230","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/BF03401339","article-title":"Metformin-induced thyrotropin suppression is not associated with cardiac effects","volume":"13","author":"Cappelli","year":"2014","journal-title":"Hormones (Athens)"},{"key":"10.1016\/j.pharep.2015.11.010_bib0235","doi-asserted-by":"crossref","first-page":"901","DOI":"10.4239\/wjd.v5.i6.901","article-title":"Diabetes mellitus and hypothyroidism: strange bedfellows or mutual companions?","volume":"5","author":"Joffe","year":"2014","journal-title":"World J Diabetes"},{"key":"10.1016\/j.pharep.2015.11.010_bib0240","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s11886-013-0410-2","article-title":"Antiarrhythmic drugs 2013: state of the art","volume":"15","author":"Kumar","year":"2013","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.pharep.2015.11.010_bib0245","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2174\/157340312803760749","article-title":"Obesity, diabetes and atrial fibrillation; epidemiology, mechanisms and interventions","volume":"8","author":"Asghar","year":"2012","journal-title":"Curr Cardiol Rev"},{"key":"10.1016\/j.pharep.2015.11.010_bib0250","first-page":"240","article-title":"The effects of amiodarone on the thyroid","volume":"22","author":"Martino","year":"2001","journal-title":"Endocr Rev"},{"key":"10.1016\/j.pharep.2015.11.010_bib0255","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.beem.2009.07.001","article-title":"Amiodarone and thyroid","volume":"23","author":"Eskes","year":"2009","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.pharep.2015.11.010_bib0260","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1177\/2042018811398516","article-title":"Management of amiodarone-related thyroid problems","volume":"2","author":"Narayana","year":"2011","journal-title":"Ther Adv Endocrinol Metab"},{"key":"10.1016\/j.pharep.2015.11.010_bib0265","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1161\/CIR.0b013e318290826d","article-title":"Management of patients with atrial fibrillation (compilation of 2006 ACCF\/AHA\/ESC and 2011 ACCF\/AHA\/HRS recommendations): a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines","volume":"127","author":"American College of Cardiology Foundation","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.pharep.2015.11.010_bib0270","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S1734-1140(10)70357-1","article-title":"Quantification of metformin by the HPLC method in brain regions, cerebrospinal fluid and plasma of rats treated with lipopolysaccharide","volume":"62","author":"Labbuzek","year":"2010","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.pharep.2015.11.010_bib0275","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1365-2265.2011.04058.x","article-title":"Thyrotropin-lowering effect of metformin in a patient with resistance to thyroid hormone","volume":"75","author":"Krysiak","year":"2011","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.pharep.2015.11.010_bib0280","doi-asserted-by":"crossref","first-page":"E510","DOI":"10.1210\/jc.2011-1754","article-title":"Metformin inhibits growth of thyroid carcinoma cells, suppresses self-renewal of derived cancer stem cells, and potentiates the effect of chemotherapeutic agents","volume":"97","author":"Chen","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharep.2015.11.010_bib0285","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1530\/EJE-13-0101","article-title":"Metformin inhibits goitrogenous effects of type 2 diabetes","volume":"169","author":"Ittermann","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.pharep.2015.11.010_bib0290","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1089\/met.2010.0026","article-title":"Metformin treatment for small benign thyroid nodules in patients with insulin resistance","volume":"9","author":"Rezz\u00f3nico","year":"2011","journal-title":"Metab Syndr Relat Disord"},{"key":"10.1016\/j.pharep.2015.11.010_bib0295","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1210\/en.2006-1237","article-title":"Metformin inhibits adenosine 5\u2032-monophosphate-activated kinase activation and prevents increases in neuropeptide Y expression in cultured hypothalamic neurons","volume":"148","author":"Chau-Van","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharep.2015.11.010_bib0300","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2265.2011.04029.x","article-title":"The interface between thyroid and diabetes mellitus","volume":"75","author":"Duntas","year":"2011","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.pharep.2015.11.010_bib0305","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/nm.2207","article-title":"Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance","volume":"16","author":"L\u00f3pez","year":"2010","journal-title":"Nat Med"},{"key":"10.1016\/j.pharep.2015.11.010_bib0310","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1440-1681.2007.04851.x","article-title":"AMP-activated protein kinase activation as a strategy for protecting vascular endothelial function","volume":"35","author":"Zou","year":"2008","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.pharep.2015.11.010_bib0315","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.09.001","article-title":"Metformin-inclusive therapy reduces the risk of stroke in patients with diabetes: a 4-year follow-up study","volume":"23","author":"Cheng","year":"2014","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.pharep.2015.11.010_bib0320","first-page":"156","article-title":"Work of the Polish Council for Control of Iodine Deficiency Disorders, and the model of iodine prophylaxis in Poland","volume":"63","author":"Szybi\u0144ski","year":"2012","journal-title":"Endokrynol Pol"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114015003588?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114015003588?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:36:21Z","timestamp":1752611781000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1016\/j.pharep.2015.11.010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S1734114015003588"],"URL":"https:\/\/doi.org\/10.1016\/j.pharep.2015.11.010","relation":{},"ISSN":["1734-1140"],"issn-type":[{"type":"print","value":"1734-1140"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of metformin on the hypothalamic-pituitary-thyroid axis in patients with type 2 diabetes and amiodarone-induced hypothyroidism","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharep.2015.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Sp. z o.o. All rights reserved.","name":"copyright","label":"Copyright"}]}}